# Vaginal Myeloid Sarcoma: A Rare Extramedullary Presentation of a Myeloid Neoplasm

**Authors:** Arif Onur Atay, Ece Sen, Ajda Gunes, Mine Hekimgil, Ali Akdemir

PMC · DOI: 10.7759/cureus.94466 · Cureus · 2025-10-13

## TL;DR

This paper presents a rare case of vaginal myeloid sarcoma, a tumor linked to leukemia, highlighting the challenges in diagnosis and treatment.

## Contribution

The novelty lies in reporting an extremely rare case of vaginal myeloid sarcoma with detailed diagnostic and treatment insights.

## Key findings

- Vaginal myeloid sarcoma can present with nonspecific symptoms, leading to delayed diagnosis.
- Imaging and immunohistochemistry are critical for accurate diagnosis of such rare tumors.
- Multidisciplinary management, including surgery and chemotherapy, is essential for treatment.

## Abstract

Myeloid sarcoma is a rare extramedullary tumor often associated with acute myeloid leukemia (AML), but it can also appear as an isolated lesion. Vaginal involvement is extremely rare and may lead to delayed diagnosis due to nonspecific symptoms. We report a 41-year-old woman with a history of two cesarean sections who presented with dyspareunia. A firm, fixed mass was palpated on the posterior vaginal wall. Transvaginal ultrasonography and pelvic MRI revealed a 7.5 × 4.3 cm mass in the rectovaginal space without rectal infiltration. The lesion was excised vaginally, and intraoperative endoscopy confirmed rectal integrity. Histopathology showed blast cell infiltration with strong CD7, CD38, CD43, CD45, and BCL-2 positivity, consistent with myeloid sarcoma. Bone marrow biopsy confirmed AML. The patient was treated with 16 cycles of chemotherapy and underwent allogeneic bone marrow transplantation. This case illustrates the diagnostic challenge of vaginal myeloid sarcoma and emphasizes the role of imaging, immunohistochemistry, and multidisciplinary management in such rare presentations.

## Linked entities

- **Proteins:** CD7 (CD7 molecule), CD38 (CD38 molecule), SPN (sialophorin), PTPRC (protein tyrosine phosphatase receptor type C), BCL2 (BCL2 apoptosis regulator)
- **Diseases:** acute myeloid leukemia (MONDO:0015667), myeloid sarcoma (MONDO:0006861)

## Full-text entities

- **Genes:** CD7 (CD7 molecule) [NCBI Gene 924] {aka GP40, LEU-9, TP41, Tp40}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, SPN (sialophorin) [NCBI Gene 6693] {aka CD43, GALGP, GPL115, LEU-22, LSN}
- **Diseases:** Myeloid Neoplasm (MESH:D009369), dyspareunia (MESH:D004414), AML (MESH:D015470), Myeloid sarcoma (MESH:D023981)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12611289/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12611289/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12611289/full.md

---
Source: https://tomesphere.com/paper/PMC12611289